What is Dr Gann?
Dr Gann, operating as the Diet of Hope Institute, is a specialized center dedicated to managing and treating dietary diseases. The institute champions the concept of 'food as medicine,' employing medically supervised visits and personalized diet plans to address chronic conditions such as heart disease, hypertension, and diabetes. Founded by Dr. Dietmar Gann and Elizabeth Gann, the organization caters to both pediatric and adult patients, offering a product line that includes Diet of Hope books and LongLife Protein, all designed to facilitate healthy dietary transformations and reduce reliance on medication.
How much funding has Dr Gann raised?
Dr Gann has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dr Gann
PPP
Public-Private Partnership
What's next for Dr Gann?
The substantial large-scale late-stage funding indicates Dr Gann's maturity and potential for significant expansion. This capital infusion is likely to fuel further development of their 'food as medicine' programs, enhance their product offerings, and potentially broaden their reach to a larger patient base. The strategic nature of the recent investment suggests a strong alignment with partners who recognize the growing demand for evidence-based nutritional therapies in chronic disease management.
See full Dr Gann company page
